In Re Trasylol Products Liability Litigation-MDL-1928

ORDER ON BAYER’S MOTION IN LI-MINE TO EXCLUDE EVIDENCE, TESTIMONY, AND ARGUMENT ALLEGING THAT BAYER PROVIDED INADEQUATE OR INCOMPLETE DATA TO THE FEDERAL FOOD AND DRUG ADMINISTRATION

DONALD M. MIDDLEBROOKS, District Judge.

THIS CAUSE comes before the Court upon Defendants’ (hereinafter, collectively, “Bayer’s”) Motion in limine (DE 5603) to exclude evidence, testimony, and argument alleging that Bayer provided inadequate or incomplete data to the federal Food and Drug Administration (“FDA”) in connection with the marketing and sale of its prescription drug Trasylol, filed on April 27, 2010, 709…